open access

Vol 71, No 5 (2021)
Invited editorial
Published online: 2021-10-13
Get Citation

Pregnancy-associated breast cancer as a screening and diagnostic challenge

Barbara Radecka12
DOI: 10.5603/NJO.2021.0059
·
Nowotwory. Journal of Oncology 2021;71(5):316-318.
Affiliations
  1. Institute of Medical Sciences, Faculty of Medicine, University of Opole, Opole, Poland
  2. Clinical Oncology Department with an Outpatient Unit, Tadeusz Koszarowski Oncology Centre in Opole, Opole, Poland

open access

Vol 71, No 5 (2021)
Invited editorial
Published online: 2021-10-13

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Pregnancy-associated breast cancer as a screening and diagnostic challenge

Journal

Nowotwory. Journal of Oncology

Issue

Vol 71, No 5 (2021)

Article type

Invited editorial

Pages

316-318

Published online

2021-10-13

DOI

10.5603/NJO.2021.0059

Bibliographic record

Nowotwory. Journal of Oncology 2021;71(5):316-318.

Authors

Barbara Radecka

References (16)
  1. Pavlidis N. Coexistence of Pregnancy and Malignancy. The Oncologist. 2002; 7(6): 573–573.
  2. Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002; 94(18): 1365–1372.
  3. Zha N, Alabousi M, Abdullah P, et al. Breast Cancer Screening in High-Risk Patients during Pregnancy and Breastfeeding: A Systematic Review of the Literature. Journal of Breast Imaging. 2019; 1(2): 92–98.
  4. Kakoulidis I, Skagias L, Politi E. Pregnancy associated breast cancer (PABC): aspects in diagnosis. Breast Dis. 2015; 35(3): 157–166.
  5. Córdoba O, Llurba E, Saura C, et al. Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes. Breast. 2013; 22(4): 515–519.
  6. Loibl S, Minckwitz Gv, Gwyn K, et al. Breast carcinoma during pregnancy. Cancer. 2006; 106(2): 237–246.
  7. Collins J, Liao S, Wile A. Surgical management of breast masses associated with pregnancy and lactation. J Reprod Med. 1995; 40(11): 785–788.
  8. Ahn BoY, Kim HH, Moon WK, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med. 2003; 22(5): 491–7; quiz 498.
  9. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol. 2000; 27(6): 623–632.
  10. Litton JK, Theriault RL, Gonzalez-Angulo AM. Breast cancer diagnosis during pregnancy. Womens Health (Lond). 2009; 5(3): 243–249.
  11. Webb JAW, Thomsen HS, Morcos SK, et al. Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005; 15(6): 1234–1240.
  12. Wang PI, Chong ST, Kielar AZ, et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol. 2012; 198(4): 778–784.
  13. Durrani S, Akbar S, Heena H. Breast Cancer During Pregnancy. Cureus. 2018; 10(7): e2941.
  14. Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. 2020; 31(6): 674–696.
  15. Kalantarova A, Zembol NJ, Kufel-Grabowska J. Pregnancy-associated breast cancer as a screening and diagnostic challenge: a case report. NOWOTWORY J Oncol. 2021; 71(3): 162–164.
  16. Jeziorski A, Nowecki ZI. Chirurgiczne leczenie zmian nowotworowych piersi — Konsensus Polskiego Towarzystwa Chirurgii Onkologicznej pod patronatem merytorycznym Konsultanta Krajowego w dziedzinie Chirurgii Onkologicznej. Via Medica, Gdańsk 2016.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl